Alternative names, keywords |
Total cholesterol, HDL cholesterol, HDL-C, high-density lipoprotein cholesterol, LDL cholesterol, LDL-C, low-density lipoprotein cholesterol, non-HDL cholesterol, triglyceride, lipids. |
||||||||||||
Samples required |
NICE CG181 recommends that patients no longer have to fast for routine lipid profile assessment. For fasting lipid profile: 12 - 14h water only. |
||||||||||||
Test indications |
|||||||||||||
Test information |
Fasting and non-fasting lipid profiles include: cholesterol |
||||||||||||
Factors affecting test performance/ results |
Cholesterol N‑Acetylcysteine at the therapeutic concentration when used as a paracetamol antidote, and the paracetamol metabolite N‑acetyl‑p‑benzoquinone imine (NAPQI) independently may cause falsely low results. Venepuncture immediately after or during the administration of metamizole may lead to falsely low results. In very rare cases, gammopathy, in particular type IgM (Waldenström’s macroglobulinemia), may cause unreliable results. HDL cholesterol Elevated concentrations of free fatty acids and denatured proteins may cause falsely elevated HDL‑cholesterol results. In rare cases, elevated immunoglobulin concentrations can lead to artificially increased HDL‑cholesterol results. Abnormal liver function affects lipid metabolism; consequently, HDL and LDL results are of limited diagnostic value. N‑Acetylcysteine at the therapeutic concentration when used as a paracetamol antidote, and the paracetamol metabolite N‑acetyl‑p‑benzoquinone imine (NAPQI), independently may cause falsely low results. Venepuncture immediately after or during the administration of metamizole may lead to falsely low results. In very rare cases, gammopathy, in particular type IgM (Waldenström’s macroglobulinemia), may cause unreliable results. Triglyceride Endogenous unesterified glycerol in the sample will falsely elevate serum triglycerides. Dicynone (Etamsylate) at therapeutic concentrations may lead to false‑low results. Ascorbic acid and calcium dobesilate cause artificially low triglyceride results. Intralipid is directly measured as analyte in this assay and leads to high triglyceride results. Paracetamol intoxications are frequently treated with N‑Acetylcysteine. N‑Acetylcysteine at a plasma concentration above 166 mg/L, and the paracetamol metabolite N‑acetyl‑p‑benzoquinone imine (NAPQI) independently may cause falsely low results. Venepuncture immediately after or during the administration of metamizole may lead to falsely low results. A significant interference may occur at plasma metamizole concentrations above 0.05 mg/mL. In very rare cases, gammopathy, in particular type IgM (Waldenström’s macroglobulinemia), may cause unreliable results.
Results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings. |
||||||||||||
Reference range |
* Source: Fasting is not routinely required for determination of a lipid profile... - a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. |
||||||||||||
Turnaround time |
Same day |
||||||||||||
Enquiries |
Biochemistry (Automation) |